The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSENS.L Share News (SENS)

  • There is currently no data for SENS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: IG Design plunges after profit warning

Wed, 26th Jan 2022 11:23

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

----------

AIM - WINNERS

----------

Sensyne Health PLC, up 25% at 19.00 pence, 12-month range 14.00p-190.00p. The healthcare technology firm says it has successfully completed a financing agreement for up to GBP11.4 million. Earlier this month, Sensyne had warned it would not be able to trade beyond February without the cash injection.

----------

Revolution Beauty Group PLC, up 14% at 110.00p, 12-month range 95.18p-173.00p. The beauty and personal care products maker and retailer reports strong sales over the peak Christmas trading period, which increased 41% year-on-year on an underlying basis. Says this was achieved despite a volatile consumer backdrop with many markets going into lockdown. Expands into US with product rollout into over 2,800 Walgreens stores.

----------

Deltex Medical Group PLC, up 5.1% at 1.26p, 12-month range 1.05p-2.34p. The medical devices manufacturer wins contract worth USD200,000 for its TrueVue monitors from an unnamed "key distributor" in the Americas.

----------

AIM - LOSERS

----------

IG Design Group PLC, down 55% at 114.00p, 12-month range 113.00p-625.00p. Shares in craft, gifting and stationery maker hit 12-month low as it says supply chain problems, rising raw material and fulfilment costs, and a drop in demand for crafting in the US have hurt trading. IG Design now expects its financial 2022 adjusted operating profit to fall to a breakeven position, resulting in full year earnings significantly below current market expectations. Says there will be no final dividend payment in relation to the current year and expects that external challenges will continue into financial 2023.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
14 May 2020 17:13

UK TRADING UPDATE SUMMARY: Byotrol Sees Continuation Of Strong Demand

UK TRADING UPDATE SUMMARY: Byotrol Sees Continuation Of Strong Demand

Read more
5 May 2020 15:38

Sensyne Health Launches BPm-Health Remote Blood Pressure Monitor

Sensyne Health Launches BPm-Health Remote Blood Pressure Monitor

Read more
22 Apr 2020 18:49

Sensyne Health Former Finance Head Headley Claims Unfair Dismissal

Sensyne Health Former Finance Head Headley Claims Unfair Dismissal

Read more
27 Mar 2020 18:44

Sensyne Health Makes Diabetes Kit Free For UK's NHS Amid Pandemic

Sensyne Health Makes Diabetes Kit Free For UK's NHS Amid Pandemic

Read more
2 Mar 2020 18:06

UPDATE: Sensyne Health Hires Former Itaconix CFO As Own Interim CFO

UPDATE: Sensyne Health Hires Former Itaconix CFO As Own Interim CFO

Read more
2 Mar 2020 11:59

Sensyne Health Chief Financial Officer Departs After Three Years

Sensyne Health Chief Financial Officer Departs After Three Years

Read more
21 Jan 2020 11:54

Contract With Bayer Boosts Sensyne Health's Revenue In First Half

Contract With Bayer Boosts Sensyne Health's Revenue In First Half

Read more
14 Jan 2020 16:01

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
23 Dec 2019 13:37

Sensyne Health Teams With Roche To Apply AI For Clinical Trial Design

Sensyne Health Teams With Roche To Apply AI For Clinical Trial Design

Read more
10 Dec 2019 18:30

Sensyne Health Directors Jenkins And Gilbert Step Down; Keogh Fills In

Sensyne Health Directors Jenkins And Gilbert Step Down; Keogh Fills In

Read more
15 Nov 2019 14:22

Sensyne Partners With Cognizant And US Data Firm For Product Launches

Sensyne Partners With Cognizant And US Data Firm For Product Launches

Read more
15 Nov 2019 12:43

Sensyne Health reveals Cognizant and Agorai as US partners

(Sharecast News) - Clinical artificial intelligence (AI) technology company Sensyne Health revealed the names of its partners for the launch and sale of its digital health software products in the United States on Friday.

Read more
30 Oct 2019 14:53

Sensyne Health Chair Swingland Resigns Amid Ongoing Health Issues

Sensyne Health Chair Swingland Resigns Amid Ongoing Health Issues

Read more
22 Oct 2019 14:52

Sensyne Health Apologies For Lack Of Remuneration Policy Consultation

Sensyne Health Apologies For Lack Of Remuneration Policy Consultation

Read more
10 Oct 2019 11:01

Sensyne Health Joins Bayer's LifeHub To Develop AI-Enabled Radiology

Sensyne Health Joins Bayer's LifeHub To Develop AI-Enabled Radiology

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.